(Image: LightSolver)
REHOVOT, Israel, Sep 8, 2026 – CollPlant has closed its acquisition of LightSolver whose Laser Processing Unit (LPU) targets high-performance computing (HPC) workloads. The deal moves CollPlant into the photonics and HPC sectors, alongside its existing regenerative medicine business. LightSolver plans to use the acquisition funding to commercialize the LPU.
“We are pleased to complete this transaction with LightSolver, marking CollPlant’s entry into the photonics computing sector,” said Yehiel Tal, chairperson and chief executive officer of CollPlant. “This exciting new field of activity will run alongside our continued and active operations in regenerative medicine.”
Dr. Ruti Ben Shlomi, founder and chief executive officer of LightSolver, commented, “Today marks an important milestone for our technology. We believe this next chapter will help us accelerate our technology roadmap and pursue commercial opportunities for our LPU platform globally. We remain focused on redefining the boundaries of computing speed and energy efficiency for our partners and the industry globally.”
At closing, CollPlant invested $5 million in LightSolver. Additional warrants become exercisable if LightSolver meets specified technological and commercial objectives.
CollPlant first announced the definitive agreement Aug. 31, 2026, and filed a Form 6-K detailing the transaction with the U.S. Securities and Exchange Commission the same day.
Source: LightSolver
About LightSolver
LightSolver develops optical computing hardware and software for optimization and engineering simulations. Founded in 2020, the company is headquartered in Tel Aviv, Israel. Its Laser Processing Unit uses coupled lasers to perform mathematical computations. The platform converts problem variables into laser couplings in an optical resonator and returns numeric results. It uses commercially available laser components and operates at room temperature. Applications include routing, scheduling, resource allocation, facility layouts, structural analysis, fluid dynamics and multiphysics simulation. Users can access an alpha-version LPU through the cloud-based LightSolver Lab. The company serves organizations in finance, logistics, manufacturing, aerospace, energy and engineering software. Boeing has funded work applying its technology to simulations of structural-material degradation.
About CollPlant
CollPlant develops collagen-based materials and products for regenerative medicine, medical aesthetics and 3D bioprinting. Founded in 2004, it is headquartered in Rehovot, Israel. The company produces recombinant human type I collagen, or rhCollagen, from tobacco plants. It uses the material in bioinks, tissue-engineering products and medical aesthetics research. Its Collink.3D product is a rhCollagen-based bioink for 3D bioprinting research. CollPlant operates research, manufacturing and production sites in Rehovot and Yessod Hama’ala, Israel. It serves medical-device companies, pharmaceutical businesses, research laboratories and tissue-engineering organizations. Its work covers tissue repair, organ manufacturing, dermal fillers and breast implants.
